companydata.dkcompanydata.dk

VITROLIFE A/S: Financial statements 2023

CVR: 27406793

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

VITROLIFE A/S (CVR 27406793) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 216,829,286 and a net result of DKK 103,152,563 compared with DKK 107,758,000 the year before. That is a decrease of 1.1% compared with the year before. Equity in the 2023 report amounted to DKK 239,413,886. The solvency ratio was 83.7%. The company had 100 employees in the financial year.

Gross Profit
DKK 216,829,286
Profit/Loss
DKK 103,152,563
Equity
DKK 239,413,886
Total Assets
DKK 286,187,145
Employees
100

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-216.8M103.2M239.4M100
2022-219.3M107.8M255.8M90
2021-194.2M96.5M247.5M86
2020-130.4M57.3M210.6M82
2019-183M94.3M153.2M81

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

VITROLIFE A/S: The 2022 annual report is outJun 20, 2023

VITROLIFE A/S has published its annual report for 2022. Gross profit came to DKK 219,325,000, and the net result was DKK 107,758,000.

Tony Patrik Tolf joins the board of VITROLIFE A/SMar 31, 2023

As of March 31, 2023, Tony Patrik Tolf has joined the board of directors of VITROLIFE A/S.

Hans Thomas Axelsson leaves the board of VITROLIFE A/SMar 31, 2023

As of March 31, 2023, Hans Thomas Axelsson has left the board of directors of VITROLIFE A/S.

Tony Patrik Tolf leaves the board of VITROLIFE A/SMar 30, 2023

As of March 30, 2023, Tony Patrik Tolf has left the board of directors of VITROLIFE A/S.

About VITROLIFE A/S

VITROLIFE A/S is a Danish company of the type Aktieselskab based in Viby J, founded in 2003. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UNISENSE FERTILITECH A/S and UNISENSE FERTILITECH ApS. The management consists of Dag Erik Rickard Ericsson. The board consists of Sten Jakob Hedén (chair), Dag Erik Rickard Ericsson and Tom Faes. The company is owned by Vitrolife AB. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 228,406,323 and a net result of DKK 110,485,853 compared with DKK 130,285,262 the year before. Equity in the 2025 report amounted to DKK 327,839,900.

Source: annual report 2025, Danish Business Authority